现场流行病学
ENGLISH ABSTRACT
河南省2023年HIV感染者常见慢性病患病情况及相关因素分析
陈昭云
赵清霞
杨萱
邓萌
赵淑娴
刘春礼
侯明杰
张志会
李琼
孙燕
作者及单位信息
·
DOI: 10.3760/cma.j.cn112338-20240626-00375
Prevalence of common chronic diseases and related factors in HIV-infected persons in Henan Province, 2023
Chen Zhaoyun
Zhao Qingxia
Yang Xuan
Deng Meng
Zhao Shuxian
Liu Chunli
Hou Mingjie
Zhang Zhihui
Li Qiong
Sun Yan
Authors Info & Affiliations
Chen Zhaoyun
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Office of Henan Provincial Clinical Research Center for Infectious Diseases (AIDS), Zhengzhou 450000, China
Zhao Qingxia
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Yang Xuan
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Deng Meng
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Office of Henan Provincial Clinical Research Center for Infectious Diseases (AIDS), Zhengzhou 450000, China
Zhao Shuxian
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Liu Chunli
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Hou Mingjie
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Zhang Zhihui
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Office of Henan Provincial Clinical Research Center for Infectious Diseases (AIDS), Zhengzhou 450000, China
Li Qiong
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
Office of Henan Provincial Clinical Research Center for Infectious Diseases (AIDS), Zhengzhou 450000, China
Sun Yan
Henan Provincial Hospital of Infectious Diseases (The Sixth People's Hospital of Zhengzhou), Zhengzhou 450000, China
·
DOI: 10.3760/cma.j.cn112338-20240626-00375
150
55
0
0
1
0
PDF下载
APP内阅读
摘要

目的分析2023年河南省HIV感染者常见慢性病(高脂血症、高血压和糖尿病)患病情况及相关因素。

方法截至2023年12月,以河南省接受抗病毒治疗(ART)及随访年龄>15岁的HIV感染者为研究对象,开展问卷调查、体检和采集血样,收集研究对象的人口学信息、ART、体重、血脂、血压和血糖等资料。采用logistic回归模型分析高脂血症、高血压和糖尿病的相关因素。

结果在HIV感染者4 023例中,高脂血症、高血压和糖尿病患病率分别为64.47%(2 594/4 023)、16.80%(676/4 023)、10.54%(424/4 023)。多因素分析结果显示,高脂血症与≥40岁年龄组、超重和肥胖、使用2种核苷类反转录酶抑制剂(NRTIs)+蛋白酶抑制剂(PIs)治疗方案和2种NRTIs+整合酶抑制剂治疗方案呈正相关,与低体重呈负相关;高血压与≥40岁年龄组、心脑血管疾病家族史、超重和肥胖、ART时间≥0.5年呈正相关,与低体重呈负相关;糖尿病与≥40岁年龄组、心脑血管疾病家族史、超重和肥胖呈正相关,与使用2种NRTIs+PIs治疗方案呈负相关。

结论2023年河南省HIV感染者高脂血症、高血压和糖尿病的患病率较高,≥40岁年龄组、超重和肥胖、有心脑血管疾病家族史者的常见慢性病的患病风险较高,建议加强HIV感染者常见慢性病的预防和管理。

HIV感染者;高脂血症;高血压;糖尿病;抗病毒治疗
ABSTRACT

ObjectiveTo understand the prevalence and related factors of three common chronic diseases, hyperlipidemia, hypertension and diabetes in HIV-infected persons.

MethodsAs of December 2023, HIV-infected persons >15 years old who are receiving antiviral therapy (ART) and follow-up in Henan Province were selected as the study objects. Questionnaires, physical examinations, and blood samples were collected to collect demographic information, ART, body weight, blood lipids, blood pressure, and blood sugar of HIV-infected persons. The logistic regression model was used to analyze the related factors of hyperlipidemia, hypertension and diabetes.

ResultsAmong 4 023 HIV-infected patients, the prevalence rates of hyperlipidemia, hypertension, and diabetes were 64.47% (2 594/4 023), 16.80% (676/4 023), and 10.54% (424/4 023), respectively. Multivariate analysis showed that hyperlipidemia was positively associated with ≥40 years of age, overweight and obesity, two nucleoside reverse transcriptase inhibitors (NRTIs) + proteasome inhibitors (PIs) regimen and two NRTIs+ integrase inhibitor regimen, and negatively associated with low body weight. Hypertension was positively correlated with the age group ≥40 years old, family history of cardiovascular and cerebrovascular diseases, overweight and obesity, ART time ≥0.5 years, and negatively correlated with low body weight. Diabetes was positively associated with age group ≥40 years, family history of cardiovascular and cerebrovascular disease, overweight and obesity, and negatively associated with the use of two NRTIs+PIs treatment regimens.

ConclusionsIn 2023, the prevalence of hyperlipidemia, hypertension, and diabetes among HIV-infected people in Henan Province was relatively high, and the risk of common chronic diseases among those ≥40 years old, overweight and obese, and those with a family history of cardiovascular and cerebrovascular diseases was also relatively high. It is recommended to strengthen the prevention and management of common chronic diseases among HIV-infected people.

HIV-infected persons;Hyperlipidemia;Hypertension;Diabetes;Antiviral therapy
Sun Yan, Email: mocdef.6ab215002naynus
引用本文

陈昭云,赵清霞,杨萱,等. 河南省2023年HIV感染者常见慢性病患病情况及相关因素分析[J]. 中华流行病学杂志,2025,46(02):258-263.

DOI:10.3760/cma.j.cn112338-20240626-00375

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
抗病毒治疗(ART)显著降低了艾滋病的发病率和死亡率,HIV感染者的预期寿命得以延长,但与年龄相关的慢性病如高脂血症、糖尿病和高血压的患病率却不断升高 1。高脂血症、高血压和糖尿病与心脑血管疾病的发病密切相关,艾滋病非相关性疾病的发病和死亡逐渐成为影响HIV感染者生存质量的主要问题 2。随着河南省HIV感染者的老龄化,其ART时间较长,存活率较高,≥10年生存率为70% 3。本研究分析2023年河南省HIV感染者常见慢性病(高脂血症、高血压和糖尿病)的患病情况及相关因素,为做好HIV感染者常见慢性病的预防和管理提供参考依据。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Ebner BF , Chueng T , Martinez CA . Epigenetics, HIV, and cardiovascular disease risk[J]. Curr Probl Cardiol, 2021,46(3):100615. DOI: 10.1016/j.cpcardiol.2020.100615 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Gueler A , Moser A , Calmy A ,et al. Life expectancy in HIV-positive persons in Switzerland:matched comparison with general population[J]. AIDS, 2017,31(3):427-436. DOI: 10.1097/qad.0000000000001335 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
孙燕,赵清霞,李超锋,. 河南省2003-2005年HIV/AIDS抗病毒治疗随访10年生存状况分析[J]. 中华流行病学杂志, 2018,39(7):966-970. DOI: 10.3760/cma.j.issn.0254-6450.2018.07.019 .
返回引文位置Google Scholar
百度学术
万方数据
Sun Y , Zhao QX , Li CF ,et al. Analysis on 10 year surviva l of HIV/AIDS patients receiving antiretroviral therapy during 2003-2005 in Henan province [J]. Chin J Epidemiol, 2018,39(7):966-970. DOI: 10.3760/cma.j.issn.0254-6450.2018.07.019 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[4]
中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中国循环杂志, 2023,38(3):237-271. DOI: 10.3969/j.issn.1000-3614.2023.03.001 .
返回引文位置Google Scholar
百度学术
万方数据
Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023)[J]. Chin Circulation J, 2023,38(3):237-271. DOI: 10.3969/j.issn.1000-3614.2023.03.001 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[5]
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 20 21 ,41(8):668-695. DOI: 10.19538/j.nk2021080106 .
返回引文位置Google Scholar
百度学术
万方数据
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part 1)[J]. Chin J Pract Intern Med, 2021,41(8):668-695. DOI: 10.19538/j.nk2021080106 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[6]
中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录)[J]. 营养学报, 2004,26(1):1-4. DOI: 10.13325/j.cnki.acta.nutr.sin.2004.01.001 .
返回引文位置Google Scholar
百度学术
万方数据
China Working Group on Obesity. Guidelines for the prevention and control of overweight and obesity in Chinese adults (excerpt)[J]. Acta Nutr Sin, 2004,26(1):1-4. DOI: 10.13325/j.cnki.acta.nutr.sin.2004.01.001 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[7]
国务院新闻办. «中国居民营养与慢性病状况报告(2020年)»有关情况举行发布会[EB/OL].( 2020-12-24)[2024-06-01]. https://www.gov.cn/xinwen/2020-12/24/content_5572983.htm.
返回引文位置Google Scholar
百度学术
万方数据
[8]
毕海涛,苏健,陈路路,. 江苏省35~75岁居民高血压患病、血压控制情况及相关因素分析[J]. 中华流行病学杂志, 2024,45(7):947-954. DOI: 10.3760/cma.j.cn112338-20240122-00034 .
返回引文位置Google Scholar
百度学术
万方数据
Bi HT , Su J , Chen LL ,et al. Prevalence of hypertension, blood pressure control and influencing factors in residents aged 35-75 years in Jiangsu Province[J]. Chin J Epidemiol, 2024,45(7):947-954. DOI: 10.3760/cma.j.cn112338-20240122-00034 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[9]
张梅,吴静,张笑,. 2018年中国成年居民高血压患病与控制状况研究[J]. 中华流行病学杂志, 2021,42(10):1780-1789. DOI: 10.3760/cma.j.cn112338-20210508-00379 .
返回引文位置Google Scholar
百度学术
万方数据
Zhang M , Wu J , Zhang X ,et al. Prevalence and control of hypertension in adults in China, 2018[J]. Chin J Epidemiol, 2021,42(10):1780-1789. DOI: 10.3760/cma.j.cn112338-20210508-00379 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[10]
Davis K , Moorhouse L , Maswera R ,et al. Associations between HIV status and self-reported hypertension in a high HIV prevalence Sub-Saharan African population:a cross-sectional study[J]. BMJ Open, 2023,13(1):e067327. DOI: 10.1136/bmjopen-2022-067327 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
World Health Organization. Diabetes China 2016 country profile[EB/OL]. ( 2016-05-31)[2022-09-27]. https://www.who.int/publications/m/item/diabetes-chn-country-profile-china-2016.
返回引文位置Google Scholar
百度学术
万方数据
[12]
叶润华,张韵秋,曹东冬,. 德宏傣族景颇族自治州HIV感染者抗病毒治疗后新发糖尿病及影响因素分析[J]. 中华流行病学杂志, 2024,45(3):358-364. DOI: 10.3760/cma.j.cn112338-20230817-00075 .
返回引文位置Google Scholar
百度学术
万方数据
Ye RH , Zhang YQ , Cao DD ,et al. Incidence of diabetes and influencing factors in HIV-infected individuals after antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture[J]. Chin J Epidemiol, 2024,45(3):358-364. DOI: 10.3760/cma.j.cn112338-20230817-00075 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[13]
Echecopar-Sabogal J , D'Angelo-Piaggio L , Chanamé-Baca DM ,et al. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients:a systematic review and meta-analysis[J]. Int J STD AIDS, 2018,29(5):443-452. DOI: 10.1177/0956462417732226 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Tadesse WT , Adankie BT , Shibeshi W ,et al. Prevalence and predictors of glucose metabolism disorders among People Living with HIV on combination antiretroviral therapy[J]. PLoS One, 2022,17(1):e0262604. DOI: 10.1371/journal.pone.0262604 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
叶荣,顾菁. HIV/AIDS患者常见慢性病患病情况[J]. 中国艾滋病性病, 2023,29(12):1371-1375. DOI: 10.13419/j.cnki.aids.2023.12.20 .
返回引文位置Google Scholar
百度学术
万方数据
Ye R , Gu J . A review of the disease frequency to chronic noncommunicable diseases common among HIV/AIDS[J]. Chin J AIDS STD, 2023,29(12):1371-1375. DOI: 10.13419/j.cnki.aids.2023.12.20 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[16]
Sun LQ , Liu JY , He Y ,et al. Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen[J]. Chin Med J (Engl), 2020,133(23):2808-2815. DOI: 10.1097/cm9.0000000000001245 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Kemal A , Teshome MS , Ahmed M ,et al. Dyslipidemia and associated factors among adult patients on antiretroviral therapy in armed force comprehensive and specialized hospital, Addis Ababa, Ethiopia[J]. HIV AIDS (Auckl) , 2020,12:221-231. DOI: 10.2147/hiv.S252391 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
马春涛,王强,张煜昆,. 2009-2019年我国艾滋病免费抗病毒治疗药品构成分析[J]. 中国医药导报, 2021,18(17):157-160, 168.
返回引文位置Google Scholar
百度学术
万方数据
Ma CT , Wang Q , Zhang YK ,et al. Analysis on the composition of free antiviral drugs for AIDS treatment in China from 2009 to 2019[J]. China Med Herald, 2021,18(17):157-160, 168.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[19]
翟优,赵英强,刘亚楠,. 河南某地区经性传播途径感染艾滋病患者高脂血症患病率及影响因素分析[J]. 中国皮肤性病学杂志, 2021,35(8):897-903. DOI: 10.13735/j.cjdv.1001-7089.202102013 .
返回引文位置Google Scholar
百度学术
万方数据
Zhai Y , Zhao YQ , Liu YN ,et al. Prevalence and influencing factors of hyperlipidemia in sexually transmitted AIDS patients in a district of Henan Province[J]. Chin J Dermatovenereol, 2021,35(8):897-903. DOI: 10.13735/j.cjdv.1001-7089.202102013 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[20]
贾皇超,姜琦,金艳涛,. 中老年人类免疫缺陷病毒和获得性免疫缺陷综合征患者血脂异常的相关危险因素分析[J]. 中华老年心脑血管病杂志, 2022,24(5):456-459. DOI: 10.3969/j.issn.1009-0126.2022.05.003 .
返回引文位置Google Scholar
百度学术
万方数据
Jia HC , Jiang Q , Jin YT ,et al. Risk factors for dyslipidemia in middle-aged and elderly HIV-infected and AIDS patients[J]. Chin J Geriatr Heart Brain Vessel Dis, 2022,24(5):456-459. DOI: 10.3969/j.issn.1009-0126.2022.05.003 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[21]
刘亚楠,马彦民,刘志斌,. 真实世界1 537例性传播HIV/AIDS患者高脂血症患病率及影响因素[J]. 中华中医药杂志, 2021,36(5):2683-2687.
返回引文位置Google Scholar
百度学术
万方数据
Liu YN , Ma YM , Liu ZB ,et al. Prevalence rate and the influencing factors of hyperlipidemia of 1 537 sexually transmitted HIV/AIDS patients in real world[J]. China J Tradit Chin Med Pharm, 2021,36(5):2683-2687.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[22]
Shah S , Hindley L , Hill A . Are new antiretroviral treatments increasing the risk of weight gain?[J]. Drugs, 2021,81(3):299-315. DOI: 10.1007/s40265-020-01457-y .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Lagathu C , Béréziat V , Gorwood J ,et al. Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment[J]. Expert Opin Drug Saf, 2019,18(9):829-840. DOI: 10.1080/14740338.2019.1644317 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
何溪,李凌华,朱媛媛,. 三种常见抗病毒方案对成人HIV/AIDS初治患者血脂的影响[J]. 广州医科大学学报, 2019,47(3):51-56. DOI: 10.3969/j.issn.2095-9664.2019.03.13 .
返回引文位置Google Scholar
百度学术
万方数据
He X , Li LH , Zhu YY ,et al. Effects of three common antiretroviral regimens on blood lipids in treatment-naive adults with HIV/AIDS[J]. Acad J Guangzhou Med Univ, 2019,47(3):51-56. DOI: 10.3969/j.issn.2095-9664.2019.03.13 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
备注信息
A
孙燕,Email: mocdef.6ab215002naynus
B

陈昭云:论文设计/撰写、数据分析;赵清霞、杨萱:研究设计、论文修改;邓萌:资料收集/整理;赵淑娴、刘春礼、侯明杰:资料收集;张志会、李琼:论文数据核对/修改;孙燕:论文撰写/修改、经费支持

C
陈昭云, 赵清霞, 杨萱, 等. 河南省2023年HIV感染者常见慢性病患病情况及相关因素分析[J]. 中华流行病学杂志, 2025, 46(2): 258-263. DOI: 10.3760/cma.j.cn112338-20240626-00375.
D
Chen ZY, Zhao QX, Yang X, et al. Prevalence of common chronic diseases and related factors in HIV-infected persons in Henan Province, 2023[J]. Chin J Epidemiol, 2025, 46(2):258-263. DOI: 10.3760/cma.j.cn112338-20240626-00375.
E
所有作者声明无利益冲突
F
河南省科技攻关项目 (242102310204)
郑州市医疗卫生领域科技创新指导计划 (2024YLZDJH380)
河南省传染病(艾滋病)临床医学研究中心开放课题 (KFKT202411)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号